Taken together, these findings were consistent with the hypothesis that FAP was relevant to the features of an immunosuppressive TME in NSCLC, which highlighted the importance of stroma-based strategies in immunotherapy. This evidence concerns the gene FAP and non-small cell lung carcinoma.